hotspot -WSS

hotspot

author：Wikipedia 2025-09-05 08:10:08 - browse：3

Biotech startup Generate Biomedicines, which uses artificial intelligence to find new drugs, raised $273 million in a Series C funding round from investors including pharma company Amgen and the VC arm of AI giant NVIDIA.

Generate was founded in 2018 by venture-creation firm Flagship Pioneering to use machine learning algorithms to identify antibodies, peptides, cell therapies, and other medicines. It launched its first clinical trial in July for a Covid monoclonal antibody, and is working on starting another clinical trial for an asthma treatment.

The biotech, which is based in Somerville, Mass., has big plans for the next couple of years: It has another 15 drug candidates in the works and plans to introduce 10 more annually, CEO Mike Nally told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Do digital therapeutics have a future in medicine?

leisure time

focus

WSS

Even great ERs can’t make up for American health disparities

Study identifies new proteins linked to dementia risk 25 years later

I learned firsthand about improving diversity in clinical trials

Ending racial health disparities hinges on penalties, political will

EF3 tornado rips through North Carolina amid extreme weather nationwide

SAMSHA loosens regulations on methadone treatment centers

focus

hotspot

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

Biden administration opens offers in Medicare drug price negotiations

Dobbs anniversary: the lost opportunity of abortion as health care

Cognito secures funding to test medical device for Alzheimer's

In age of alternative facts, a scholarly course on calling out crap

Indian pharmaceutical industry in denial over drug

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Study identifies new proteins linked to dementia risk 25 years later

Heart attack and stroke risk calculators need revising

Stanford president's case begs question: Who takes blame?

knowledge

Texas Department of Public Safety speaks out on migrant abuse allegations

General Catalyst, Summa Health deal will turn on physician buy

Juul spent big to court Black leaders to promote its e

Vertigo drug brings hope for rare neuron disorder, Niemann

Awakening the world to the whoosh: A patient's crusade

Study identifies new proteins linked to dementia risk 25 years later

leisure time

explore

focus

focus